Brief: Biosyent Releases Q2 And H1 2022 Financial Results
23/08/2022 22:01
Aug 23 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT RELEASES Q2 AND H1 2022 FINANCIAL RESULTS
* BIOSYENT INC - Q2 2022 TOTAL NET REVENUES OF $6,634,875
DECREASED BY 9% VERSUS Q2 2021
* BIOSYENT INC - QTRLY EPS OF $0.10
Source text for Eikon: ID:nGNX4HKXvx
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid